Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

Completed · Phase 2

Conditions studied: Hypercholesterolemia

In brief

The purpose of this research study is to see how ETC-1002 is tolerated in the body, to measure the amount of ETC-1002 in the blood, and to determine how ETC-1002 affects the level of LDL-cholesterol (bad cholesterol) and other markers of health and disease in blood and urine in patients with elevated LDL-cholesterol with or without statin intolerance.

Key facts

Study ID
NCT01941836
Run by
Esperion Therapeutics, Inc.
People needed
349
Starts
2013-09-01
Expected to finish
2014-11-01
Last updated by the study team
2019-03-29

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.